The Blue Jays placed reliever Tommy Nance on the 15-day injured list due to right forearm discomfort, marking another injury setback this season. In his place, left-handed pitcher Adam Macko, the team's No. 21 prospect, has been promoted from Triple-A Buffalo to make his MLB debut. Macko has demonstrated potential as a multi-inning reliever, previously pitching well for Team Canada and holding a 4.50 ERA over 18 innings in Triple-A. This call-up is crucial as the Blue Jays navigate injuries, especially since Nance has proven to be a reliable pitcher over the past two seasons. Macko's fastball, typically sitting between 93-95 mph, coupled with his strong curveball and slider, positions him as a valuable asset for the team's bullpen.

By the Numbers
  • Nance had a 3.86 ERA with 25 strikeouts over 21 innings in 2026.
  • Macko pitched 18 innings in Triple-A with a 4.50 ERA.
Yes, But

While Macko has potential, his transition to the major leagues may involve challenges, especially given his relatively low innings pitched in the past due to injuries, raising questions about his durability and effectiveness in a high-pressure role.

State of Play
  • The Blue Jays are struggling with multiple injuries in their bullpen.
  • Macko's promotion highlights the team's reliance on young talent as they adapt to their pitching issues.
What's Next

Macko is expected to play an important role in the team's bullpen, especially as the Blue Jays utilize bullpen days. His performance in the coming games will be closely monitored to assess his adaptation to major league competition.

Bottom Line

The promotion of Adam Macko serves as a pivotal moment for the Blue Jays, emphasizing their need for reliable pitchers amid injuries. His potential to effectively contribute could be crucial in stabilizing the bullpen as the team navigates a challenging season.